213 results
8-K
YTEN
Yield10 Bioscience Inc
4 Aug 14
Metabolix, Inc. Enters into Private Placement Agreement with Investors to Raise $25 Million in Equity Financing
12:00am
Agreement and, by its nature, is incomplete. A copy of the Purchase Agreement is filed as Exhibit 10.1 to this Form 8-K and is incorporated herein … of the Common Stock.
The foregoing is a summary description of certain terms of the Certificate of Designation and, by its nature, is incomplete. A copy
FWP
YTEN
Yield10 Bioscience Inc
25 Oct 19
Free writing prospectus
12:49pm
business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 … and reliability of raw data, the voluntary nature of the data gathering process and other limitations and uncertainties.In addition, we do not know all
8-K
EX-10.1
YTEN
Yield10 Bioscience Inc
1 May 23
Entry into a Material Definitive Agreement
2:51pm
properties owned or held under lease or the nature of their activities makes such qualification necessary, except for such failures to be so qualified … of the Securities Act, the availability of which depends upon, among other things, the bona fide nature of the Purchaser’s investment intent
S-1
EX-10.18
7a3915z m4gk
14 Jul 06
IPO registration
12:00am
S-1/A
q3g 7tn65wqvzihix
31 Aug 06
IPO registration (amended)
12:00am
CORRESP
sb72n3vmi9t5 yogzx
25 Sep 12
Correspondence with SEC
12:00am